Literature DB >> 12148581

Anti-tumour studies of metal chelates of synthetic curcuminoids.

V D John1, G Kuttan, K Krishnankutty.   

Abstract

Four synthetic curcuminoids, 1,7-bis(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione (curcumin1), 1,7-bis(piperonyl)-1,6-heptadiene-3, 5-dione (piperonyl curcumin), 1, 7-bis(2-hydroxy naphthyl)-1, 6-heptadiene-2, 5-dione (2-hydroxy naphthyl curcumin), 1,1-bis(phenyl)-1, 3, 8, 10- undecatetraene-5, 7-dione (cinnamyl curcumin) and their copper(II) complexes were investigated for their possible cytotoxic and antitumour activities. Copper chelates of synthetic curcuminoids showed enhanced antitumour activity. All the compounds were found to be cytotoxic to cultured L929 cells, concentration needed for 50% inhibition being around 10 microg/ml for curcuminoids and 1 microg/ml for their copper complexes. Copper complexes of curcuminoids with a hydroxy group on the ring such as 2-hydroxy naphthyl curcumin were found to be most active (1 microg/ml produced 60.45+/-2.1% cell death). Copper complex of cinnamyl curcumin which has an extended conjugation showed considerable activity in increasing the life span (ILS=78.6%) of ascites tumour bearing animals. Whereas complex of piperonyl curcumin was found to show least antitumour activity. Copper chelates of curcuminoids showed a significant reduction (p< .001) of solid tumour volume in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12148581

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  6 in total

Review 1.  Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Subhash Padhye
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Curcuminoid ligands for sensitization of near-infrared lanthanide emission.

Authors:  M D Seltzer; S Fallis; R A Hollins; N Prokopuk; R N Bui
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

3.  Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.

Authors:  Subhash Padhye; Sanjeev Banerjee; Deepak Chavan; Shubhangini Pandye; K Venkateswara Swamy; Shadan Ali; Jing Li; Q Ping Dou; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2009-08-28       Impact factor: 4.200

4.  New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells.

Authors:  Subhash Padhye; Huanjie Yang; Abeda Jamadar; Qiuzhi Cindy Cui; Deepak Chavan; Kristin Dominiak; Jaclyn McKinney; Sanjeev Banerjee; Q Ping Dou; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

Review 5.  A new dawn for the use of traditional Chinese medicine in cancer therapy.

Authors:  Harendra S Parekh; Gang Liu; Ming Q Wei
Journal:  Mol Cancer       Date:  2009-03-20       Impact factor: 27.401

6.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.